Indazole estrogens: Highly selective ligands for the estrogen receptor β

Journal of Medicinal Chemistry

Volumn 48, Issue 4, 2005, Pages 1132-1144

  De Angelis, Meri ^a   Stossi, Fabio ^b   Carlson, Kathryn A ^a   Katzenellenbogen, Benita S ^b   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 2 (4 HYDROXYPHENYL) 2H INDAZOL 5 OL; 3 CHLORO 2 (4 HYDROXYPHENYL) 2H INDAZOL 5 OL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; POLARIZATION;

BINDING, COMPETITIVE; CELL LINE, TUMOR; ESTROGEN RECEPTOR BETA; HUMANS; IMIDAZOLES; LIGANDS; RADIOLIGAND ASSAY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 13944255737     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049223g     Document Type: Article

References (41)

1. Turner, R. T.; Rickard, D.; Spelsberg, T. C.; Sibonga, J. D. The basic biology of estrogen and bone. Osteoporosis; Humana Press: 2002; pp 309-330.
2. Maran, A.; Turner, R. T. Effects of estrogen on bone. Recent Research Developments in Endocrinology; 2001; p 327.
3. Mendelsohn, M. E.; Karas, R. H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340, 1801-1811.
4. Mendelsohn, M. E. Protective effects of estrogen on the cardiovascular system. Am. J. Cardiol. 2002, 89, 12E-17E; discussion 17E-18E.
5. Behl, C. Oestrogen as a neuroprotecitve hormone. Nature Rev. Neurosci. 2002, 3, 433-442.
6. Zhao, L.; Wu, T.-W.; Brinton, R. D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004, 1010, 22-34.
7. Mosselman, S.; Polman, J.; Dijkema, R. ERb: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392, 49-53.
8. Kuiper, G. G.; Enmark, E.; Pelto-Huikko, M.; Nilsson, S.; Gustafsson, J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1896, 93, 5925-5930.
9. Pike, A. C. W.; Brzozowski, A. M.; Hubbard, R. E.; Bonn, T.; Thorsell, A.-G.; Engstrom, O.; Ljunggren, J.; Gustafsson, J.-A.; Carlquist, M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 1999, 18, 4608-4618.
10. Weihua, Z.; Andersson, S.; Cheng, G.; Simpson Evan, R.; Warner, M.; Gustafsson, J.-A. Update on estrogen signaling. FEBS Lett. 2003, 546, 17-24.
11. Mitra, S. W.; Hoskin, E.; Yudkovitz, J.; Pear, L.; Wilkinson, H. A.; Hayashi, S.; Pfaff, D. W.; Ogawa, S.; Rohrer, S. P.; Schaeffer, J. M.; McEwen, B. S.; Alves, S. E. Immunolocalization of Estrogen Receptor {beta} in the Mouse Brain: Comparison with Estrogen Receptor {alpha}. Endocrinology 2003, 144, 2055-2067.
12. Shughrue, P. J.; Lane, M. V.; Merchenthaler, I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comput. Neurol. 1997, 388, 507-525.
13. Stossi, F.; Barnett, D. H.; Frasor, J.; Komm, B.; Lyttle, C. R.; Katzenellenbogen, B. S. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: Distinct and common target genes for these receptors. Endocrinology 2004, 145, 3473-3486.
14. Kian, T. M.; Rogatsky, I.; Tzagarakis-Foster, C.; Cvoro, A.; An, J.; Christy, R. J.; Yamamoto, K. R.; Leitman, D. C. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol. Biol. Cell 2004, 15, 1262-1272.
15. Monroe, D. G.; Getz, B. J.; Johnsen, S. A.; Riggs, B. L.; Khosla, S.; Spelsberg, T. C. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalphaor ERbeta. J. Cell. Biochem. 2003, 90, 315-326.
16. Sun, J.; Meyers, M. J.; Fink, B. E.; Rajendran, R.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology 1999, 140, 800-804.
17. Mortensen, D. S.; Rodriguez, A. L.; Carlson, K. E.; Sun, J.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Synthesis and biological evaluation of a novel series of furans: Ligands selective for estrogen receptor alpha. J. Med. Chem. 2001, 44, 3838-3848.
18. Kuiper, G. G.; Carlsson, B.; Grandien, K.; Enmark, E.; Haggblad, J.; Nilsson, S.; Gustafsson, J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138, 863-870.
19. Henke, B. R.; Consler, T. G.; Go, N.; Hale, R. L.; Hohman, D. R.; Jones, S. A.; Lu, A. T.; Moore, L. B.; Moore, J. T.; Orband-Miller, L. A.; Robinett, R. G.; Shearin, J.; Spearing, P. K.; Stewart, E. L.; Turnbull, P. S.; Weaver, S. L.; Williams, S. P.; Wisely, G. B.; Lambert, M. H. A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. J. Med. Chem. 2002, 45, 5492-5505.
20. Yang, C.; Edsall, R., Jr.; Harris, H. A.; Zhang, X.; Manas, E. S.; Mewshaw, R. E. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives. Bioorg. Med. Chem. 2004, 12, 2553-2570.
21. Meyers, M. J.; Sun, J.; Carlson, K. E.; Marriner, G. A.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Estrogen receptor-beta potency-selective ligands: Structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem. 2001, 44, 4230-4251.
22. Schopfer, U.; Schoeffter, P.; Bischoff, S. F.; Nozulak, J.; Feuerbach, D.; Floersheim, P. Toward selective ERbeta agonists for central nervous system disorders: Synthesis and characterization of aryl benzthiophenes. J. Med. Chem. 2002, 45, 1399-1401.
23. Malamas, M. S.; Manas, E. S.; McDevitt, R, E.; Gunawan, I.; Xu, Z. B.; Collini, M. D.; Miller, C. P.; Dinh, T.; Henderson, R. A.; Keith, J. C., Jr.; Harris, H. A. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J. Med. Chem. 2004, 47, 5021-5040.
24. Barlaam, B.; Bernstein, P.; Dantzman, C.; Warwick, P. Preparation of benzoxazoles and benzothiazoles as selective ligands for human b-estrogen receptor. An 2002:504768, WO02/051821, 2002.
25. Barlaam, B.; Dock, S.; Folmer, J. Preparation of benzimidazoles as selective estrogen receptor-b ligand. An 2002:449659, WO02/ 046168, 2002.
26. Harris, H. A.; Albert, L. M.; Leathurby, Y.; Malamas, M. S.; Mewshaw, R. E.; Miller, C. P.; Kharode, Y. P.; Marzolf, J.; Komm, B. S.; Winneker, R. C.; Frail, D. E.; Henderson, R. A.; Zhu, Y.; Keith, J. C., Jr. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003, 144, 4241-4249.
27. Fink, B. E.; Mortensen, D. S.; Stauffer, S. R.; Aron, Z. D.; Katzenellenbogen, J. A. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chem. Biol. 1999, 6, 205-219.
28. Song, J. J.; Yee, N. K. A novel synthesis of 2-aryl-2H-indazoles via a palladium-catalyzed intramolecular amination reaction. Org. Lett. 2000, 2, 519-521.
29. Ghosh, A. K.; Mukhopadhyaya, J. K.; Ghatak, U. R. Regioselective aryl radical cyclisation. Part 2. Synthesis of octahydro-1H-dibenzo[a,d]cycloheptenes through 7-endo ring closure. J Chem Soc, Perkin Trans 1 1997, 18, 2747-2756.
30. Waalwijk, P. S.; Cohen-Fernandes, P.; Habraken, C. L. Indazole studies. 3. The bromination of 2-phenyl-2H-indazole. Formation and structure determination of mono-, di-, and tribromo-2-phenyl-2H-indazoles. J. Org. Chem. 1984, 49, 3404-3403.
31. Collot, V.; Dallemagne, P.; Bovy, P. R.; Rault, S. Suzuki-type cross-coupling reaction of 3-iodoindazoles with aryl boronic acids: A general and flexible route to 3-arylindazoles. Tetrahedron 1999, 55, 6917-6922.
32. Tamao, K.; Kiso, Y.; Sumitani, K.; Kumada, M. Alkyl group isomerization in the cross-coupling reaction of secondary alkyl Grignard reagents with organic halides in the presence of nickel-phosphine complexes as catalysts. J. Am. Chem. Soc. 1972, 94, 9268-9269.
33. Littke, A. F.; Schwarz, L.; Fu, G. C. Pd/P(t-Bu)(3): A mild and general catalyst for Stille reactions of aryl chlorides and aryl bromides. J. Am. Chem. Soc. 2002, 124, 6343-6348.
34. Chen, Q.-Y. Trifluoromethylation of organic halides with difluorocarbene precursors. J. Fluorine Chem. 1995, 72, 241-246.
35. Jin, F.; Confalone, P, N. Palladium-catalyzed cyanation reactions of aryl chlorides. Tetrahedron Lett. 2000, 41, 3271-3273.
36. Ardakani, M. A.; Smalley, R. K.; Smith, R. H. A New Synthesis of 2-Aryl-3-chloro-2H-indazoles. Synthesis 1979, 4, 308-310.
37. Boojamra, C. G.; Burow, K. M.; Thompson, L. A.; Ellman, J. A. Solid-Phase Synthesis of 1,4-Benzodiazepine-2,5-diones. Library Preparation and Demonstration of Synthesis Generality. J. Org. Chem. 1997, 62, 1240-1256.
38. Liu, Q.; Tor, Y. Simple conversion of aromatic amines into azides. Org Lett 2003, 5, 2571-2572.
39. Katzenellenbogen, J. A.; Johnson, H. J., Jr.; Myers, H. N. Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry 1973, 12, 4085-4092.
40. Carlson, K. E.; Choi, I.; Gee, A.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction. Biochemistry 1997, 36, 14897-14905.
41. McInerney, E. M.; Tsai, M. J.; O'Malley, B. W.; Katzenellenbogen, B. S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10069-10073.